Back to News
Market Impact: 0.2
Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System
Source: GlobeNewswire
Healthcare & BiotechRegulation & LegislationProduct Launches
Teknova and Pluristyx announced that the PluriFreeze™ cryopreservation system is covered by a Type II FDA Drug Master File and is available for developers to cross-reference. The filing may streamline regulatory documentation for cell-therapy and other bioprocessing developers using the system, supporting commercial adoption, though no financial impact or customer commitments were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
PLUR0.65
TKNO0.65
More News
- Mark Ruffalo says Paramount’s $111 billion Warner Bros. deal ‘Will stifle creativity, weaken free speech, and cost people their jobs’
- States, cities sue U.S. agencies over weaker vehicle fuel economy rules
- Anthropic warns government attitudes may hurt customer ties, IPO prospectus shows: Reuters
- Paramount and Warner Bros Discovery to become Skydance
- FAA says Boeing 737 Max software glitch not a flight-safety issue
- Paramount’s Warner Bros. megamerger will just be called Skydance